{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T00:53:14Z","timestamp":1794099194989,"version":"4.8.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Gallbladder cancer (GBC) is the commonest gastrointestinal cancer in women of north India. Precursor epithelial lesions in GBC are known; however, the role of xanthogranulomatous (XG) inflammation in the pathogenesis of GBC is unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>To analyze the role of precursor lesions in the pathogenesis of GBC we studied the immunohistochemical (IHC) expression of p53, carcino-embryonic antigen (CEA) and carbohydrate antigen 19.9 (CA-19.9) in GBC, chronic cholecystitis (CC), XG cholecystitis (XGC) and precursor lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>The study included 51 GBC, 68 CC, 42 XGC and 10 normal gallbladders. All cases were evaluated for presence of precursor lesions and IHC was performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>p53 immunoreactivity was found in 55% GBC, 32% of dysplasia with malignancy and in 14% of dysplasia with CC. Sixteen percent GBC had associated XG inflammation. Normal and metaplastic epithelium in CC and in XGC did not express p53. CEA expression was apical in normal and inflammatory GBs (CC, XGC), while cytoplasmic focal to diffuse positivity was seen in 82% GBC. CA-19.9 expression was seen in all cases of normal and inflammatory GBs; however, foci of antral metaplasia were negative. Seventy-five percent of GBC expressed CA-19.9; all negative cases were high-grade on histology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Altered CEA expression is seen in GBC as compared to normal and inflammatory gallbladders. Loss of expression of CA19.9 in antral metaplasia and poorly differentiated GBC may indicate that it is a marker of biliary differentiation. p53 over-expression seen in GBC and in dysplasia associated with malignancy and with CC suggests that p53 mutation and dysplasia are early events in the evolution of GBC. Epithelial metaplasia and XG inflammation are often associated with GBC but do not appear to play a role in its pathogenesis through the p53 pathway.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/0022-3859.70933","type":"journal-article","created":{"date-parts":[[2010,10,7]],"date-time":"2010-10-07T04:58:33Z","timestamp":1286427513000},"page":"262-266","source":"Crossref","is-referenced-by-count":18,"title":["p53, carcinoembryonic antigen and carbohydrate antigen 19.9 expression in gall bladder cancer, precursor epithelial lesions and xanthogranulomatous cholecystitis"],"prefix":"10.4103","volume":"56","author":[{"given":"V","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Krishnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VK","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20240205","first-page":"24","article-title":"Epidemiology of digestive tract cancers in India IV. Gall bladder and pancreas","volume":"18","author":"Dhir","year":"1999","journal-title":"Indian J Gastroenterol"},{"key":"R2-5-20240205","first-page":"209","article-title":"Gallbladder cancer: An 'Indian' disease'","volume":"16","author":"Kapoor","year":"2003","journal-title":"Natl Med J India"},{"key":"R3-5-20240205","first-page":"31","article-title":"Xanthogranulomatous cholecystitis: Differentiation from associated gall bladder carcinoma","volume":"26","author":"Rao","year":"2005","journal-title":"Trop Gastroenterol"},{"key":"R4-5-20240205","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00268-003-7161-y","article-title":"Xanthogranulomatous cholecystitis: 15 years' experience","volume":"28","author":"Guzman-Valdivia","year":"2004","journal-title":"World J Surg"},{"key":"R5-5-20240205","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/pgmj.65.766.528","article-title":"Xanthogranulomatous cholecystitis associated with carcinoma of the gallbladder","volume":"65","author":"Benbow","year":"1989","journal-title":"Postgrad Med J"},{"key":"R6-5-20240205","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/1097-0142(19881001)62:7<1425::AID-CNCR2820620730>3.0.CO;2-T","article-title":"Carcinoma of the gallbladder. A clinicopathology of 103 patients and a newly proposed staging","volume":"62","author":"Yamaguchi","year":"1988","journal-title":"Cancer"},{"key":"R7-5-20240205","first-page":"256","article-title":"Xanthogranulomatous cholecystitis (XGC): A clinicopathological study of 21 cases","volume":"32","author":"Solanki","year":"1989","journal-title":"Indian J Pathol Microbiol"},{"key":"R8-5-20240205","first-page":"935","article-title":"Genetic analysis of xanthogranulomatous cholecystitis: Precancerous lesion of gallbladder cancer?","volume":"49","author":"Takada","year":"2002","journal-title":"Hepatogastroenterology"},{"key":"R9-5-20240205","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/1097-0142(19830915)52:6<1069::AID-CNCR2820520623>3.0.CO;2-1","article-title":"Carcinoembryonic antigen in normal, preneoplastic and neoplastic gallbladder epithelium","volume":"52","author":"Albores-Saavedra","year":"1983","journal-title":"Cancer"},{"key":"R10-5-20240205","first-page":"49","article-title":"CEA immunohistochemical localization is correlated with growth and metastasis of human gallbladder carcinoma","volume":"16","author":"Dowaki","year":"2000","journal-title":"Int J Oncol"},{"key":"R11-5-20240205","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/1097-0142(19800301)45:5<919::AID-CNCR2820450514>3.0.CO;2-4","article-title":"The precursor lesions of invasive gallbladder carcinoma. Hyperplasia, atypical hyperplasia and carcinoma in situ","volume":"45","author":"Albores-Saavedra","year":"1980","journal-title":"Cancer"},{"key":"R12-5-20240205","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0046-8177(96)90109-4","article-title":"p53 protein overexpression in gallbladder carcinoma and its precursor lesions: An immunohistochemical study","volume":"27","author":"Wistuba","year":"1996","journal-title":"Hum Pathol"},{"key":"R13-5-20240205","doi-asserted-by":"crossref","first-page":"386","DOI":"10.5858\/2005-129-386-PPOGDA","article-title":"Putative precursors of gallbladder dysplasia: A review of 400 routinely resected specimens","volume":"129","author":"Mukhopadhyay","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"R14-5-20240205","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jso.20527","article-title":"Preneoplastic lesions in gallbladder cancer","volume":"93","author":"Roa","year":"2006","journal-title":"J Surg Oncol"},{"key":"R15-5-20240205","first-page":"521","article-title":"p53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions","volume":"43","author":"Ajiki","year":"1996","journal-title":"Hepatogastroenterology"},{"key":"R16-5-20240205","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/jcp.47.5.453","article-title":"Clinical importance of p53 protein in gall bladder carcinoma and its precursor lesions","volume":"47","author":"Wee","year":"1994","journal-title":"J Clin Pathol"},{"key":"R17-5-20240205","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/path.1711700111","article-title":"p53 and c-erb-2 protein expression in adenocarcinoma and epithelial dysplasia of the gallbladder","volume":"170","author":"Kamel","year":"1993","journal-title":"J Pathol"},{"key":"R18-5-20240205","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1046\/j.1365-2559.1997.2420850.x","article-title":"p53 tumor suppressor gene protein expression in early and advanced gallbladder carcinoma","volume":"31","author":"Roa","year":"1997","journal-title":"Histopathology"},{"key":"R19-5-20240205","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/ejso.1999.0763","article-title":"Overexpression of p53 protein in gallbladder carcinoma in North India","volume":"26","author":"Misra","year":"2000","journal-title":"Eur J Surg Oncol"},{"key":"R20-5-20240205","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1471-2407-6-126","article-title":"Preliminary study of p53 and c-erb B-2 expression in gall bladder cancer in Indian patients","volume":"10","author":"Chaube","year":"2006","journal-title":"BMC Cancer"},{"key":"R21-5-20240205","first-page":"1127","article-title":"Expression of the c-erb-B2 and p53 protein in gallbladder carcinomas","volume":"8","author":"Kim","year":"2001","journal-title":"Oncol Rep"},{"key":"R22-5-20240205","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/1097-0142(19830915)52:6<1069::AID-CNCR2820520623>3.0.CO;2-1","article-title":"Carcinoembryonic antigen in normal, preneoplastic and neoplastic gallbladder epithelium","volume":"52","author":"Albores-Saavedra","year":"1983","journal-title":"Cancer"},{"key":"R23-5-20240205","first-page":"49","article-title":"CEA immunohistochemical localization is correlated with growth and metastasis of human gallbladder carcinoma","volume":"16","author":"Dowaki","year":"2000","journal-title":"Int J Oncol"},{"key":"R24-5-20240205","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1155\/2000\/865068","article-title":"Gallbladder carcinomas: An immunoprognostic evaluation of p53, Bcl-2, CEA and alpha-fetoprotein","volume":"14","author":"Kanthan","year":"2000","journal-title":"Can J Gastroenterol"},{"key":"R25-5-20240205","first-page":"160","article-title":"Diagnostic value of serum CA242, CA 19-9, CA 15-3 and CA 125 in patients with carcinoma of the gallbladder","volume":"27","author":"Shukla","year":"2006","journal-title":"Trop Gastroenterol"},{"key":"R26-5-20240205","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1080\/07357900802711304","article-title":"Fragile histidine triad (FHIT) gene and its association with p53 expression in the progression of gall bladder cancer","volume":"27","author":"Priya","year":"2009","journal-title":"Cancer Invest"}],"container-title":["Journal of Postgraduate Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00005257-201056040-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:18:02Z","timestamp":1787768282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005257-201056040-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.4103\/0022-3859.70933","relation":{},"ISSN":["0022-3859"],"issn-type":[{"value":"0022-3859","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}